GlaxoSmithKline S.A.E reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was EGP 576.44 million compared to EGP 546.72 million a year ago. Net income was EGP 27.16 million compared to EGP 48.91 million a year ago. Basic earnings per share was EGP 0.33 compared to EGP 0.59 a year ago.
For the nine months, sales was EGP 1,576.75 million compared to EGP 1,269.06 million a year ago. Net income was EGP 46.73 million compared to EGP 920.72 million a year ago. Basic earnings per share was EGP 0.56 compared to EGP 11.02 a year ago.